SPOP and cancer: a systematic review

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer initiation and progression involve mutations in oncogenes and tumor suppressor genes, leading to pathway dysregulation.
• Speckle Type POZ Protein (SPOP), a tumor suppressor gene, is frequently altered in diverse cancers, exhibiting pleiotropic effects.
• SPOP functions as an E3 ubiquitin ligase substrate binding subunit of the proteasome complex, crucial for protein degradation.

Purpose of the Study:

• To review current literature on cancer-specific alterations of the Speckle Type POZ Protein (SPOP).
• To identify SPOP targets that become stabilized upon SPOP alteration.
• To elucidate the key regulatory pathways dysregulated as a consequence of SPOP mutations or downregulation.

Main Methods:

• Literature review of studies investigating SPOP alterations in various cancer types.
• Analysis of identified SPOP targets and their functional consequences.
• Examination of the impact of SPOP alterations on proteasome pathway function and associated regulatory networks.

Main Results:

• SPOP alterations (mutations or downregulation) are implicated in the disruption of the proteasome pathway in multiple cancers.
• SPOP dysfunction leads to the stabilization of its direct protein targets.
• Stabilized SPOP targets contribute to the dysregulation of critical cellular pathways, promoting tumorigenesis.

Conclusions:

• SPOP plays a significant role in cancer development through its regulation of protein degradation.
• Understanding SPOP alterations and their downstream effects is crucial for developing targeted cancer therapies.
• Further research into SPOP's role in tumorigenesis can uncover novel therapeutic strategies.